Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2007002572) NATTOKINASE FOR REDUCING WHOLE BLOOD VISCOSITY
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2007/002572 International Application No.: PCT/US2006/024772
Publication Date: 04.01.2007 International Filing Date: 23.06.2006
Chapter 2 Demand Filed: 22.10.2007
IPC:
A61K 38/43 (2006.01) ,A61P 9/10 (2006.01) ,A61P 9/12 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
43
Enzymes; Proenzymes; Derivatives thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9
Drugs for disorders of the cardiovascular system
10
for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9
Drugs for disorders of the cardiovascular system
12
Antihypertensives
Applicants:
N-ZYMECEUTICALS, INC. [US/US]; 450 Lewis Street, 3rd Floor P.O. Box 278 Pagosa Springs, CO 81147, US (AllExceptUS)
HOLSWORTH, Ralph, E. [US/US]; US (UsOnly)
Inventors:
HOLSWORTH, Ralph, E.; US
Agent:
BRINCKERHOFF, Courtenay, C. ; Foley & Lardner LLP Washington Harbour 3000 K St., NW, Suite 500 Washington, DC 20007-5143, US
Priority Data:
60/693,40924.06.2005US
Title (EN) NATTOKINASE FOR REDUCING WHOLE BLOOD VISCOSITY
(FR) NATTOKINASE POUR REDUIRE LA VISCOSITE DU SANG TOTAL
Abstract:
(EN) Disclosed is a method for reducing whole blood viscosity in a patient in need thereof. The method includes administering a composition that comprises nattokinase. The composition may be administered to any patient that may benefit from a reduction in blood viscosity, such as a patient having or at risk for vascular diseases and conditions.
(FR) L'invention concerne un procédé servant à réduire la viscosité du sang total chez un patient qui en a besoin. Le procédé selon l'invention consiste à administrer une composition comprenant de la nattokinase. Cette composition peut être administrée à tout patient pouvant tirer profit d'une réduction de sa viscosité sanguine, par exemple à un patient atteint ou susceptible d'être atteint de maladies ou de troubles vasculaires.
front page image
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP1901771